| positive regulation of activation of membrane attack complex | GO:0001970 | 2 | 0.444 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.330 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.330 | |
| hemostasis | GO:0007599 | 78 | 0.318 | |
| amine metabolic process | GO:0009308 | 45 | 0.308 | |
| protein activation cascade | GO:0072376 | 19 | 0.286 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.257 | |
| coagulation | GO:0050817 | 78 | 0.255 | |
| blood coagulation | GO:0007596 | 76 | 0.212 | |
| activation of membrane attack complex | GO:0001905 | 4 | 0.199 | |
| fibrinolysis | GO:0042730 | 3 | 0.194 | |
| regulation of complement activation | GO:0030449 | 7 | 0.179 | |
| regulation of coagulation | GO:0050818 | 31 | 0.176 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.173 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.168 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.166 | |
| negative regulation of coagulation | GO:0050819 | 11 | 0.156 | |
| activation of immune response | GO:0002253 | 138 | 0.151 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.151 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.145 | |
| immune effector process | GO:0002252 | 321 | 0.132 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.127 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.123 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.115 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.115 | |
| oxidation reduction process | GO:0055114 | 342 | 0.112 | |
| gland development | GO:0048732 | 330 | 0.111 | |
| cellular homeostasis | GO:0019725 | 240 | 0.108 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.101 | |
| negative regulation of fibrinolysis | GO:0051918 | 1 | 0.101 | |
| protein processing | GO:0016485 | 163 | 0.101 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.100 | |
| transmembrane transport | GO:0055085 | 412 | 0.098 | |
| wound healing | GO:0042060 | 157 | 0.096 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.096 | |
| response to stilbenoid | GO:0035634 | 22 | 0.095 | |
| negative regulation of blood coagulation | GO:0030195 | 11 | 0.092 | |
| regulation of protein activation cascade | GO:2000257 | 7 | 0.092 | |
| negative regulation of hemostasis | GO:1900047 | 11 | 0.091 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.090 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.089 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.089 | |
| regulation of wound healing | GO:0061041 | 40 | 0.088 | |
| spermatogenesis | GO:0007283 | 284 | 0.086 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.086 | |
| protein maturation | GO:0051604 | 176 | 0.085 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.085 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.084 | |
| anion transport | GO:0006820 | 177 | 0.083 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.082 | |
| steroid metabolic process | GO:0008202 | 119 | 0.078 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.075 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.073 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.071 | |
| response to steroid hormone | GO:0048545 | 56 | 0.070 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.069 | |
| liver development | GO:0001889 | 66 | 0.067 | |
| positive regulation of protein activation cascade | GO:2000259 | 2 | 0.067 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.066 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.065 | |
| drug transmembrane transport | GO:0006855 | 5 | 0.061 | |
| regulation of plasminogen activation | GO:0010755 | 4 | 0.060 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.060 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.060 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.058 | |
| complement activation | GO:0006956 | 16 | 0.057 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.057 | |
| humoral immune response | GO:0006959 | 57 | 0.057 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.055 | |
| cation homeostasis | GO:0055080 | 212 | 0.052 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.052 | |
| male gamete generation | GO:0048232 | 285 | 0.051 | |
| lipid homeostasis | GO:0055088 | 63 | 0.051 | |
| endocrine process | GO:0050886 | 39 | 0.051 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.051 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.050 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.050 | |
| inflammatory response | GO:0006954 | 244 | 0.050 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.050 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.049 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.048 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.047 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.047 | |
| regulation of protein localization | GO:0032880 | 231 | 0.047 | |
| organelle assembly | GO:0070925 | 177 | 0.046 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.046 | |
| maintenance of location | GO:0051235 | 89 | 0.046 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.046 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.045 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.045 | |
| cellular biogenic amine metabolic process | GO:0006576 | 28 | 0.045 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.044 | |
| ossification | GO:0001503 | 216 | 0.044 | |
| negative regulation of complement activation | GO:0045916 | 3 | 0.044 | |
| response to acid chemical | GO:0001101 | 111 | 0.043 | |
| benzene containing compound metabolic process | GO:0042537 | 5 | 0.043 | |
| negative regulation of wound healing | GO:0061045 | 14 | 0.043 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.043 | |
| regulation of intestinal cholesterol absorption | GO:0030300 | 4 | 0.043 | |
| folic acid containing compound metabolic process | GO:0006760 | 3 | 0.042 | |
| regulation of system process | GO:0044057 | 200 | 0.041 | |
| lipid localization | GO:0010876 | 126 | 0.041 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.041 | |
| stress response to metal ion | GO:0097501 | 3 | 0.041 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.040 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.040 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.039 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.039 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.039 | |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.038 | |
| adaptive immune response | GO:0002250 | 155 | 0.038 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.038 | |
| fat cell differentiation | GO:0045444 | 160 | 0.037 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.037 | |
| inter male aggressive behavior | GO:0002121 | 3 | 0.036 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.034 | |
| sensory system development | GO:0048880 | 3 | 0.034 | |
| regulation of defense response | GO:0031347 | 233 | 0.034 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.034 | |
| positive regulation of plasminogen activation | GO:0010756 | 2 | 0.034 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.033 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.033 | |
| innate immune response | GO:0045087 | 157 | 0.033 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.033 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.033 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.032 | |
| response to drug | GO:0042493 | 75 | 0.031 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.031 | |
| sterol metabolic process | GO:0016125 | 58 | 0.031 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.031 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.031 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.031 | |
| germ cell development | GO:0007281 | 185 | 0.030 | |
| organophosphate ester transport | GO:0015748 | 28 | 0.030 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.030 | |
| regulation of protein processing | GO:0070613 | 96 | 0.030 | |
| negative regulation of protein activation cascade | GO:2000258 | 3 | 0.030 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.030 | |
| cellular response to lipid | GO:0071396 | 145 | 0.030 | |
| regulation of microvillus assembly | GO:0032534 | 3 | 0.030 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.030 | |
| one carbon metabolic process | GO:0006730 | 1 | 0.030 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.030 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.030 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.030 | |
| muscle tissue development | GO:0060537 | 308 | 0.029 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.029 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.029 | |
| transition metal ion homeostasis | GO:0055076 | 54 | 0.029 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.029 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.029 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.029 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.029 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.029 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.029 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.028 | |
| cholesterol transport | GO:0030301 | 38 | 0.028 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.028 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.028 | |
| multicellular organism growth | GO:0035264 | 161 | 0.028 | |
| iron ion homeostasis | GO:0055072 | 36 | 0.027 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.026 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.026 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.026 | |
| protein oligomerization | GO:0051259 | 67 | 0.026 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.026 | |
| tetrapyrrole metabolic process | GO:0033013 | 22 | 0.026 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.026 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.025 | |
| hormone metabolic process | GO:0042445 | 86 | 0.025 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.025 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.025 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.025 | |
| regulation of cell growth | GO:0001558 | 91 | 0.024 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.024 | |
| sperm motility | GO:0030317 | 47 | 0.024 | |
| regulation of humoral immune response | GO:0002920 | 22 | 0.024 | |
| chemotaxis | GO:0006935 | 247 | 0.024 | |
| axonogenesis | GO:0007409 | 274 | 0.023 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.023 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.023 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.023 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.023 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.023 | |
| defense response to other organism | GO:0098542 | 197 | 0.023 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.023 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.023 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.023 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.023 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.022 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.022 | |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.022 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.022 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.022 | |
| cellular response to peptide | GO:1901653 | 92 | 0.022 | |
| sterol transport | GO:0015918 | 38 | 0.022 | |
| lipid transport | GO:0006869 | 98 | 0.022 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.022 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.021 | |
| lipid storage | GO:0019915 | 36 | 0.021 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.021 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.021 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.021 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.021 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.021 | |
| plasma lipoprotein particle organization | GO:0071827 | 11 | 0.021 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.021 | |
| response to metal ion | GO:0010038 | 47 | 0.021 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.020 | |
| activation of mapk activity | GO:0000187 | 59 | 0.020 | |
| positive regulation of complement activation | GO:0045917 | 2 | 0.020 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.020 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.020 | |
| bone mineralization | GO:0030282 | 54 | 0.020 | |
| cholesterol efflux | GO:0033344 | 24 | 0.020 | |
| muscle cell development | GO:0055001 | 133 | 0.019 | |
| alcohol catabolic process | GO:0046164 | 16 | 0.019 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.019 | |
| placenta blood vessel development | GO:0060674 | 31 | 0.019 | |
| cell adhesion | GO:0007155 | 329 | 0.019 | |
| cholesterol catabolic process | GO:0006707 | 5 | 0.019 | |
| intracellular protein transport | GO:0006886 | 204 | 0.019 | |
| epithelium migration | GO:0090132 | 63 | 0.019 | |
| response to inorganic substance | GO:0010035 | 96 | 0.019 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.019 | |
| b cell activation | GO:0042113 | 161 | 0.019 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.019 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.019 | |
| multi organism behavior | GO:0051705 | 62 | 0.018 | |
| organic anion transport | GO:0015711 | 137 | 0.018 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.018 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.018 | |
| response to purine containing compound | GO:0014074 | 28 | 0.018 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.018 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.018 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.018 | |
| myosin filament organization | GO:0031033 | 3 | 0.018 | |
| maternal process involved in female pregnancy | GO:0060135 | 32 | 0.018 | |
| regulation of microvillus organization | GO:0032530 | 3 | 0.018 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.018 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.018 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.017 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.017 | |
| response to peptide hormone | GO:0043434 | 127 | 0.017 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.017 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.017 | |
| endothelial cell migration | GO:0043542 | 44 | 0.017 | |
| negative regulation of iron ion transport | GO:0034757 | 1 | 0.017 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.017 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.017 | |
| response to oxidative stress | GO:0006979 | 123 | 0.017 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.017 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.017 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.017 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.017 | |
| cation transport | GO:0006812 | 399 | 0.017 | |
| skeletal system development | GO:0001501 | 356 | 0.017 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.017 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.017 | |
| regulation of acute inflammatory response | GO:0002673 | 27 | 0.017 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.017 | |
| placenta development | GO:0001890 | 140 | 0.016 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.016 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.016 | |
| response to insulin | GO:0032868 | 100 | 0.016 | |
| cellular response to antibiotic | GO:0071236 | 4 | 0.016 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.016 | |
| organ regeneration | GO:0031100 | 2 | 0.016 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.016 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.016 | |
| defense response to virus | GO:0051607 | 68 | 0.016 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.016 | |
| cofactor transport | GO:0051181 | 4 | 0.016 | |
| angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 3 | 0.016 | |
| acute inflammatory response | GO:0002526 | 41 | 0.015 | |
| icosanoid metabolic process | GO:0006690 | 33 | 0.015 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.015 | |
| jak stat cascade | GO:0007259 | 42 | 0.015 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.015 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.015 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.015 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.015 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.015 | |
| cellular response to gonadotropin stimulus | GO:0071371 | 4 | 0.015 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.015 | |
| endocytosis | GO:0006897 | 168 | 0.015 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.015 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.015 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.015 | |
| lipid catabolic process | GO:0016042 | 69 | 0.015 | |
| protein lipid complex remodeling | GO:0034368 | 6 | 0.015 | |
| cell junction organization | GO:0034330 | 77 | 0.015 | Fly |
| response to retinoic acid | GO:0032526 | 56 | 0.015 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.015 | |
| cytokine production | GO:0001816 | 319 | 0.015 | |
| ammonium transmembrane transport | GO:0072488 | 2 | 0.015 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.015 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.015 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.015 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.015 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.015 | |
| digestive system development | GO:0055123 | 200 | 0.015 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.015 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.015 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.015 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.014 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.014 | |
| male gonad development | GO:0008584 | 88 | 0.014 | |
| myosin filament assembly | GO:0031034 | 2 | 0.014 | |
| glycosylation | GO:0070085 | 62 | 0.014 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.014 | |
| angiogenesis | GO:0001525 | 201 | 0.014 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.014 | |
| protein localization to organelle | GO:0033365 | 185 | 0.014 | |
| positive regulation of cytoskeleton organization | GO:0051495 | 49 | 0.014 | |
| steroid esterification | GO:0034433 | 3 | 0.014 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.014 | |
| positive regulation of dna biosynthetic process | GO:2000573 | 4 | 0.014 | |
| b cell differentiation | GO:0030183 | 78 | 0.014 | |
| mapk cascade | GO:0000165 | 281 | 0.014 | |
| interleukin 8 production | GO:0032637 | 4 | 0.014 | |
| regulation of bone remodeling | GO:0046850 | 28 | 0.014 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.014 | |
| single organism nuclear import | GO:1902593 | 95 | 0.013 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.013 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.013 | |
| nephron tubule development | GO:0072080 | 84 | 0.013 | |
| regulation of cell activation | GO:0050865 | 289 | 0.013 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.013 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.013 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.013 | |
| glucose homeostasis | GO:0042593 | 128 | 0.013 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.013 | |
| response to peptide | GO:1901652 | 136 | 0.013 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.013 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.013 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.013 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.013 | |
| cellular response to follicle stimulating hormone stimulus | GO:0071372 | 1 | 0.013 | |
| regulation of glial cell differentiation | GO:0045685 | 41 | 0.013 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.013 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.013 | |
| inorganic anion transport | GO:0015698 | 43 | 0.013 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.013 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.013 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.013 | |
| positive regulation of steroid hormone secretion | GO:2000833 | 2 | 0.013 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.013 | |
| positive regulation of hemostasis | GO:1900048 | 10 | 0.013 | |
| female sex differentiation | GO:0046660 | 84 | 0.013 | |
| protein lipid complex subunit organization | GO:0071825 | 12 | 0.013 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.013 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.013 | |
| cell proliferation in forebrain | GO:0021846 | 30 | 0.012 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.012 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.012 | |
| female gonad development | GO:0008585 | 71 | 0.012 | |
| organic hydroxy compound catabolic process | GO:1901616 | 25 | 0.012 | |
| respiratory system development | GO:0060541 | 190 | 0.012 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.012 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.012 | |
| sterol homeostasis | GO:0055092 | 45 | 0.012 | |
| embryonic placenta development | GO:0001892 | 98 | 0.012 | |
| urogenital system development | GO:0001655 | 261 | 0.012 | |
| epithelial cell migration | GO:0010631 | 63 | 0.012 | |
| positive regulation of protein maturation | GO:1903319 | 7 | 0.012 | |
| positive regulation of granulocyte macrophage colony stimulating factor production | GO:0032725 | 3 | 0.012 | |
| ovulation cycle | GO:0042698 | 59 | 0.012 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.012 | |
| hepatocyte growth factor receptor signaling pathway | GO:0048012 | 3 | 0.012 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.012 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.012 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.012 | |
| regulation of toll signaling pathway | GO:0008592 | 1 | 0.012 | |
| translational initiation | GO:0006413 | 24 | 0.012 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.012 | |
| cervix development | GO:0060067 | 2 | 0.012 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.012 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.012 | |
| aromatic amino acid family catabolic process | GO:0009074 | 4 | 0.012 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.012 | |
| arachidonic acid metabolic process | GO:0019369 | 14 | 0.012 | |
| toxin metabolic process | GO:0009404 | 5 | 0.012 | |
| regulation of renin secretion into blood stream | GO:1900133 | 4 | 0.012 | |
| maintenance of location in cell | GO:0051651 | 24 | 0.012 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.012 | |
| renal tubule development | GO:0061326 | 87 | 0.012 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.012 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.012 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.012 | |
| regulation of complement activation classical pathway | GO:0030450 | 1 | 0.012 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.012 | |
| gonad development | GO:0008406 | 141 | 0.011 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.011 | |
| regulation of fibrinolysis | GO:0051917 | 1 | 0.011 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.011 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.011 | |
| dibenzo p dioxin metabolic process | GO:0018894 | 1 | 0.011 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.011 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.011 | |
| porphyrin containing compound metabolic process | GO:0006778 | 22 | 0.011 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.011 | |
| response to organophosphorus | GO:0046683 | 22 | 0.011 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.011 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.011 | |
| urea transmembrane transport | GO:0071918 | 2 | 0.011 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.011 | |
| response to follicle stimulating hormone | GO:0032354 | 1 | 0.011 | |
| forebrain development | GO:0030900 | 302 | 0.011 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.011 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.011 | |
| wound healing involved in inflammatory response | GO:0002246 | 4 | 0.011 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.011 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.011 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.011 | |
| adiponectin activated signaling pathway | GO:0033211 | 4 | 0.011 | |
| regulation of granulocyte macrophage colony stimulating factor production | GO:0032645 | 3 | 0.011 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.011 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.011 | |
| cellular response to metal ion | GO:0071248 | 31 | 0.011 | |
| phagocytosis | GO:0006909 | 66 | 0.011 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.011 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.011 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.011 | |
| cellular response to thyroid hormone stimulus | GO:0097067 | 1 | 0.011 | |
| regulation of secretion | GO:0051046 | 274 | 0.011 | |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.011 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.011 | |
| progesterone metabolic process | GO:0042448 | 4 | 0.011 | |
| biomineral tissue development | GO:0031214 | 64 | 0.011 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.011 | |
| maternal placenta development | GO:0001893 | 20 | 0.011 | |
| ear development | GO:0043583 | 200 | 0.011 | |
| glial cell differentiation | GO:0010001 | 131 | 0.011 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.011 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.011 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.010 | |
| platelet activation | GO:0030168 | 40 | 0.010 | |
| regulation of lipoprotein lipase activity | GO:0051004 | 4 | 0.010 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.010 | |
| kidney development | GO:0001822 | 213 | 0.010 | |
| female gamete generation | GO:0007292 | 74 | 0.010 | |
| response to camp | GO:0051591 | 14 | 0.010 | |
| cell junction assembly | GO:0034329 | 52 | 0.010 | Fly |
| regulation of lipoprotein metabolic process | GO:0050746 | 4 | 0.010 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.010 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.010 | |
| sphingolipid biosynthetic process | GO:0030148 | 26 | 0.010 | |
| axon ensheathment | GO:0008366 | 76 | 0.010 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.010 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.010 | |
| c4 dicarboxylate transport | GO:0015740 | 3 | 0.010 | |
| neuronal action potential | GO:0019228 | 54 | 0.010 | |
